Literature DB >> 22658544

Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.

Kyle C Kurek1, Valerie L Luks, Ugur M Ayturk, Ahmad I Alomari, Steven J Fishman, Samantha A Spencer, John B Mulliken, Margot E Bowen, Guilherme L Yamamoto, Harry P W Kozakewich, Matthew L Warman.   

Abstract

Congenital lipomatous overgrowth with vascular, epidermal, and skeletal anomalies (CLOVES) is a sporadically occurring, nonhereditary disorder characterized by asymmetric somatic hypertrophy and anomalies in multiple organs. We hypothesized that CLOVES syndrome would be caused by a somatic mutation arising during early embryonic development. Therefore, we employed massively parallel sequencing to search for somatic mosaic mutations in fresh, frozen, or fixed archival tissue from six affected individuals. We identified mutations in PIK3CA in all six individuals, and mutant allele frequencies ranged from 3% to 30% in affected tissue from multiple embryonic lineages. Interestingly, these same mutations have been identified in cancer cells, in which they increase phosphoinositide-3-kinase activity. We conclude that CLOVES is caused by postzygotic activating mutations in PIK3CA. The application of similar sequencing strategies will probably identify additional genetic causes for sporadically occurring, nonheritable malformations.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658544      PMCID: PMC3370283          DOI: 10.1016/j.ajhg.2012.05.006

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

Review 1.  PI3K: a potential therapeutic target for cancer.

Authors:  Yingwei Chen; Bao-Can Wang; Yongtao Xiao
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

2.  PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.

Authors:  Kyle C Kurek; Emily Howard; L B Tennant; Joseph Upton; Ahmad I Alomari; Patricia E Burrows; Kim Chalache; David J Harris; Cameron C Trenor; Charis Eng; Steven J Fishman; John B Mulliken; Antonio R Perez-Atayde; Harry P W Kozakewich
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

3.  An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.

Authors:  Kathryn M Kinross; Karen G Montgomery; Margarete Kleinschmidt; Paul Waring; Ivan Ivetac; Anjali Tikoo; Mirette Saad; Lauren Hare; Vincent Roh; Theo Mantamadiotis; Karen E Sheppard; Georgina L Ryland; Ian G Campbell; Kylie L Gorringe; James G Christensen; Carleen Cullinane; Rodney J Hicks; Richard B Pearson; Ricky W Johnstone; Grant A McArthur; Wayne A Phillips
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

4.  Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients.

Authors:  A I Alomari; G Chaudry; G Rodesch; P E Burrows; J B Mulliken; E R Smith; S J Fishman; D B Orbach
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-10       Impact factor: 3.825

5.  Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.

Authors:  Helen He Zhu; Kaihong Ji; Nazilla Alderson; Zhao He; Shuangwei Li; Wen Liu; Dong-Er Zhang; Linheng Li; Gen-Sheng Feng
Journal:  Blood       Date:  2011-03-30       Impact factor: 22.113

6.  A mosaic activating mutation in AKT1 associated with the Proteus syndrome.

Authors:  Marjorie J Lindhurst; Julie C Sapp; Jamie K Teer; Jennifer J Johnston; Erin M Finn; Kathryn Peters; Joyce Turner; Jennifer L Cannons; David Bick; Laurel Blakemore; Catherine Blumhorst; Knut Brockmann; Peter Calder; Natasha Cherman; Matthew A Deardorff; David B Everman; Gretchen Golas; Robert M Greenstein; B Maya Kato; Kim M Keppler-Noreuil; Sergei A Kuznetsov; Richard T Miyamoto; Kurt Newman; David Ng; Kevin O'Brien; Steven Rothenberg; Douglas J Schwartzentruber; Virender Singhal; Roberto Tirabosco; Joseph Upton; Shlomo Wientroub; Elaine H Zackai; Kimberly Hoag; Tracey Whitewood-Neal; Pamela G Robey; Pamela L Schwartzberg; Thomas N Darling; Laura L Tosi; James C Mullikin; Leslie G Biesecker
Journal:  N Engl J Med       Date:  2011-07-27       Impact factor: 91.245

7.  Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.

Authors:  Jessica R Adams; Keli Xu; Jeff C Liu; Natalia M Ruiz Agamez; Amanda J Loch; Ruth G Wong; Wei Wang; Katherine L Wright; Timothy F Lane; Eldad Zacksenhaus; Sean E Egan
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

8.  Construction of normalized RNA-seq libraries for next-generation sequencing using the crab duplex-specific nuclease.

Authors:  Danos C Christodoulou; Joshua M Gorham; Daniel S Herman; J G Seidman
Journal:  Curr Protoc Mol Biol       Date:  2011-04

9.  An activating mutation of AKT2 and human hypoglycemia.

Authors:  K Hussain; B Challis; N Rocha; F Payne; M Minic; A Thompson; A Daly; C Scott; J Harris; B J L Smillie; D B Savage; U Ramaswami; P De Lonlay; S O'Rahilly; I Barroso; R K Semple
Journal:  Science       Date:  2011-10-06       Impact factor: 47.728

10.  Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome.

Authors:  Margot E Bowen; Eric D Boyden; Ingrid A Holm; Belinda Campos-Xavier; Luisa Bonafé; Andrea Superti-Furga; Shiro Ikegawa; Valerie Cormier-Daire; Judith V Bovée; Twinkal C Pansuriya; Sérgio B de Sousa; Ravi Savarirayan; Elena Andreucci; Miikka Vikkula; Livia Garavelli; Caroline Pottinger; Toshihiko Ogino; Akinori Sakai; Bianca M Regazzoni; Wim Wuyts; Luca Sangiorgi; Elena Pedrini; Mei Zhu; Harry P Kozakewich; James R Kasser; Jon G Seidman; Kyle C Kurek; Matthew L Warman
Journal:  PLoS Genet       Date:  2011-04-14       Impact factor: 5.917

View more
  144 in total

Review 1.  Approach to the Diagnosis of Overgrowth Syndromes.

Authors:  Mohnish Suri
Journal:  Indian J Pediatr       Date:  2015-12-18       Impact factor: 1.967

Review 2.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

Review 3.  Molecules in medicine mini-review: isoforms of PI3K in biology and disease.

Authors:  Bart Vanhaesebroeck; Maria A Whitehead; Roberto Piñeiro
Journal:  J Mol Med (Berl)       Date:  2015-12-10       Impact factor: 4.599

4.  What is your diagnosis?

Authors:  Manuela Panteliades; Claudia Marcia Resende Silva; Bernardo Gontijo
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

5.  A somatic MAP3K3 mutation is associated with verrucous venous malformation.

Authors:  Javier A Couto; Matthew P Vivero; Harry P W Kozakewich; Amir H Taghinia; John B Mulliken; Matthew L Warman; Arin K Greene
Journal:  Am J Hum Genet       Date:  2015-02-26       Impact factor: 11.025

6.  PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.

Authors:  Laura A Jansen; Ghayda M Mirzaa; Gisele E Ishak; Brian J O'Roak; Joseph B Hiatt; William H Roden; Sonya A Gunter; Susan L Christian; Sarah Collins; Carissa Adams; Jean-Baptiste Rivière; Judith St-Onge; Jeffrey G Ojemann; Jay Shendure; Robert F Hevner; William B Dobyns
Journal:  Brain       Date:  2015-02-25       Impact factor: 13.501

7.  Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder.

Authors:  Deidre R Krupp; Rebecca A Barnard; Yannis Duffourd; Sara A Evans; Ryan M Mulqueen; Raphael Bernier; Jean-Baptiste Rivière; Eric Fombonne; Brian J O'Roak
Journal:  Am J Hum Genet       Date:  2017-08-31       Impact factor: 11.025

Review 8.  Somatic mosaicism: implications for disease and transmission genetics.

Authors:  Ian M Campbell; Chad A Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2015-04-21       Impact factor: 11.639

9.  Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin.

Authors:  Teng Zhang; Yufeng Yao; Jingjing Wang; Yong Li; Ping He; Vinay Pasupuleti; Zhengkun Hu; Xinzhen Jia; Qixue Song; Xiao-Li Tian; Changqing Hu; Qiuyun Chen; Qing Kenneth Wang
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

10.  Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?

Authors:  Dennis Döcker; Max Schubach; Moritz Menzel; Christiane Spaich; Heinz-Dieter Gabriel; Martin Zenker; Deborah Bartholdi; Saskia Biskup
Journal:  Eur J Hum Genet       Date:  2014-06-18       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.